Furthermore, overexpression of Bmi1 was reported to be associated with poor survival in OSCC patients 38, 39, 40, and targeting Bmi1 could inhibit tumor growth and overcome chemoresistance 21, 41. The gene discussed is BMI1; the disease is neoplasm.